Home > M&A deals 2021 > Ardian invests in Proteor SAS
Growth Capital · Medical Products · January 2021

Ardian invests in Proteor SAS

On January 13, 2021, Ardian invested in Proteor SAS, a medical products company in France.

Deal at a glance

AnnouncedJanuary 13, 2021 TypeGrowth Capital TargetProteor SAS Buyer Ardian SectorMedical Products LocationFrance ValueNot disclosed

Target company

Proteor SAS
France
Medical Productssector
2004founded
Activestatus
View the company profile →

Buyer

Ardian
Private equity firm · 421 deals on record
  • 8th transaction in medical products
  • 180th transaction in France
421deals, all time
9in this sector
2026latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

PflegiaSame lead buyer · Jul 2026
Munich Electrification GmbHSame lead buyer · Jul 2026
Taxually Korlatolt Felelossegu TarsasagSame lead buyer · May 2022
Aquilab SASSame sector and country · Apr 2022
Impeto Medical SASSame sector and country · Jan 2022

Questions about this deal

Who acquired Proteor SAS?Ardian invested in Proteor SAS on January 13, 2021.

What type of deal was it?It was a growth capital in the medical products sector in 2021.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).